ARC
IDIX

Absolute Return Capital’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Absolute Return Capital’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-621,490
Closed -$3.23M – 772
2013
Q3 		$3.23M Hold
621,490
– – 0.04% 411
2013
Q2 		$2.24M Buy
+621,490
New +$2.54M 0.03% 518

Other funds holding IDIX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Absolute Return Capital's IDIX Position: Q4 2013 in Review

Absolute Return Capital sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q4 2013, closing a stake of 621,490 shares — an estimated $3.23M sold.

Absolute Return Capital first reported a position in IDIX in Q2 2013 and held it in 2 quarters. The position peaked at $3.23M in Q3 2013. 88 funds tracked by Wall St. Rank hold IDIX as of Q4 2013.

  • Absolute Return Capital reported no remaining IDENIX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Absolute Return Capital sold 621,490 IDENIX PHARMACEUTICALS INC shares in Q4 2013, an estimated $3.23M.
  • Absolute Return Capital first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Absolute Return Capital's IDENIX PHARMACEUTICALS INC position peaked at $3.23M in Q3 2013.
  • 88 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q4 2013.

Based on Absolute Return Capital's 13F filing for Q4 2013, filed 10 Feb 2014.